Chia Tai Pharmaceutical and others establish private equity fund management companies in Zhuhai

People’s Finance News, April 2—According to the Qichacha app, recently, Zhuhai Zhongsheng Runkang Private Equity Fund Management Co., Ltd. was established. The legal representative is Xie Qirun, with registered capital of 10 million yuan. Its business scope includes: private equity fund management, venture capital fund management services; and business management consulting. Qichacha’s equity-through analysis shows that the company is jointly held by Sinochem Pharmaceutical Investment (Beijing) Group Co., Ltd. and Zhuhai Runkang Enterprise Management Partnership Enterprise (Limited Partnership).

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments